Search results for "CAG"

showing 10 items of 492 documents

Glucagon-Like Peptide 1 and Taste Perception: From Molecular Mechanisms to Potential Clinical Implications

2021

Preclinical studies provided some important insights into the action of glucagon-like peptide 1 (GLP-1) in taste perception. This review examines the literature to uncover some molecular mechanisms and connections between GLP-1 and the gustatory coding. Local GLP-1 production in the taste bud cells, the expression of GLP-1 receptor on the adjacent nerves, a functional continuum in the perception of sweet chemicals from the gut to the tongue and an identification of GLP-1 induced signaling pathways in peripheral and central gustatory coding all strongly suggest that GLP-1 is involved in the taste perception, especially sweet. However, the impact of GLP-1 based therapies on gustatory coding i…

0301 basic medicineTasteendocrine systemobesitymedia_common.quotation_subject030209 endocrinology & metabolismReviewBiologyCatalysisGlucagon-Like Peptide-1 Receptorlcsh:ChemistryInorganic Chemistrytaste03 medical and health sciences0302 clinical medicineTreatment targetsTonguetongueGlucagon-Like Peptide 1PerceptionmedicineAnimalsHumansGLP-1 Sweet Taste Tongue Animals Glucagon-Like Peptide-1 Receptor Humans Obesity Signal Transduction Taste Taste Buds Taste PerceptionPhysical and Theoretical ChemistryReceptorTaste Bud Cellslcsh:QH301-705.5Molecular BiologySpectroscopymedia_commonOrganic Chemistrydigestive oral and skin physiologyTaste PerceptionGeneral MedicineTaste BudsGlucagon-like peptide-1Computer Science Applications030104 developmental biologymedicine.anatomical_structurelcsh:Biology (General)lcsh:QD1-999Signal transductionGLP-1Neurosciencesweethormones hormone substitutes and hormone antagonistsSignal TransductionInternational Journal of Molecular Sciences
researchProduct

Reorganization of platelet membrane sphingomyelins by adenosine diphosphate and ticagrelor

2018

IF 2.766 (2017); International audience; Platelets are major targets for the treatment of thrombo-embolic disorders. Their plasma membrane contains specialized microdomains enriched in sphingomyelins and free cholesterol including membrane receptors. P2Y12 receptors need to be situated in these domains to be able to conduct activation signaling by adenosine diphosphate (ADP). We studied the impact of ticagrelor, a P2Y12 antagonist, and ADP on the composition and distribution of sphingomyelins in detergent-resistant membrane (DRM) of platelet membranes. Platelets were obtained from healthy donors. DRMs of platelet membranes were isolated in 4 experimental groups: control; ADP, with platelets…

0301 basic medicineTicagrelorStimulation030204 cardiovascular system & hematologyBiochemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineP2Y12Cell surface receptordetergent-resistant membranemedicinePlateletMolecular BiologyTriton X-100Cell MembraneOrganic ChemistrycholesterolCell Biology[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismSphingomyelinsAdenosine DiphosphateAdenosine diphosphate030104 developmental biologyMembranechemistryBiophysicsP2Y12 receptorSphingomyelinTicagrelormedicine.drug
researchProduct

2018

Obesity is one of the major public health issues, and its prevalence is steadily increasing all the world over. The endocannabinoid system (ECS) has been shown to be involved in the intake of palatable food via activation of cannabinoid 1 receptor (CB1R). However, the involvement of lingual CB1R in the orosensory perception of dietary fatty acids has never been investigated. In the present study, behavioral tests on CB1R−/− and wild type (WT) mice showed that the invalidation of Cb1r gene was associated with low preference for solutions containing rapeseed oil or a long-chain fatty acid (LCFA), such as linoleic acid (LA). Administration of rimonabant, a CB1R inverse agonist, in mice also br…

0301 basic medicinechemistry.chemical_classificationTastemedicine.medical_specialtyNutrition and DieteticsbiologyCD36Linoleic acidGPR120Fatty acidProglucagonEndocannabinoid system03 medical and health scienceschemistry.chemical_compound030104 developmental biology0302 clinical medicineEndocrinologychemistryRimonabantInternal medicinemedicinebiology.protein030217 neurology & neurosurgeryFood Sciencemedicine.drugNutrients
researchProduct

Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors

2020

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dipeptidyl peptidase-4 (DPP-4) inhibitors are so called “incretin-based therapies” (IBTs) that represent innovative therapeutic approaches and are commonly used in clinical practice for the treatment of type 2 diabetes mellitus (T2DM). The cardiovascular outcome trials (CVOTs) have provided useful information that has helped to shape changes in clinical practice guidelines for the management of T2DM. At the same time, the mechanisms that may explain the nonglycemic and cardiovascular (CV) benefits of these medications are still being explored. A summary of the main findings from CVOTs performed to-date with particular emphasis on vari…

0301 basic medicineendocrine systemmedicine.medical_specialtyDipeptidyl Peptidase 4Endocrinology Diabetes and MetabolismIncretin030209 endocrinology & metabolismClass effectBody weightCardiovascular SystemIncretinsGlucagon-Like Peptide-1 Receptor03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineType 2 diabetes mellitusmedicineAnimalsHumansIntensive care medicineGlucagon-like peptide 1 receptorDipeptidyl-Peptidase IV Inhibitorsbusiness.industryDPP-4 Inhibitorsdigestive oral and skin physiologyType 2 Diabetes MellitusCardiovascular riskDPP4- inhibitorClinical Practice030104 developmental biologyCardiovascular DiseasesGlucagon-like peptide 1 receptor agonistbusinessCardiovascular outcomesMetabolism
researchProduct

Influence of glucagon-like peptide 2 on energy homeostasis

2016

Glucagon like peptide-2 (GLP-2) is a gastrointestinal hormone released from enteroendocrine L-type cells together with glucagon like peptide-1 in response to dietary nutrients. GLP-2 acts through a specific receptor, the GLP-2 receptor, mainly located in the gut and in the brain. Classically, GLP-2 is considered a trophic hormone involved in the maintenance of intestinal epithelial morphology and function. This role has been targeted for therapies promoting repair and adaptive growth of the intestinal mucosa. Recently, GLP-2 has been shown to exert beneficial effects on glucose metabolism specially in conditions related to increased uptake of energy, such as obesity. Several actions of GLP-…

0301 basic medicineendocrine systemmedicine.medical_specialtyPhysiologyAppetiteEnteroendocrine cellBiologyCarbohydrate metabolismSettore BIO/09 - FisiologiaBiochemistryGlucagonEnergy homeostasis03 medical and health sciencesCellular and Molecular NeuroscienceEndocrinologyIntestinal mucosaFood intakeInternal medicineGlucagon-Like Peptide 2medicineAnimalsHomeostasisHumansObesitydigestive oral and skin physiologyInsulin resistanceGlucagon-like peptide-2Gastrointestinal TractGlucose030104 developmental biologyEndocrinologyGastrointestinal hormoneGastrointestinal AbsorptionL-type enteroendocrine cellEnergy IntakeEnergy MetabolismGLP-2hormones hormone substitutes and hormone antagonistsHomeostasisPeptides
researchProduct

2020

Cannabinoids are known to influence hormone secretion of pancreatic islets via G protein-coupled cannabinoid receptor type 1 and 2 (CB1 and CB2). The present study was designed to further investigate the impact of cannabinoid receptors on the parameters involved in insulin secretion and blood glucose recognition. To this end, CB1 and CB2 receptor knockout mice (10–12 week old, both sexes) were characterised at basal state and compared to wild-type mice. The elimination of cannabinoid receptor signalling resulted in alterations of blood glucose concentrations, body weights and insulin levels. Changes were dependent on the deleted receptor type and on the sex. Analyses at mRNA and protein lev…

0301 basic medicinemedicine.medical_specialtyGlucagonCatalysisInorganic Chemistry03 medical and health sciences0302 clinical medicineInternal medicineCannabinoid receptor type 1medicineCannabinoid receptor type 2Physical and Theoretical ChemistryMolecular BiologySpectroscopybiologyChemistryGlucokinaseOrganic ChemistryGlucose transporterGeneral MedicineComputer Science Applications030104 developmental biologyEndocrinology030220 oncology & carcinogenesisbiology.proteinGLUT2lipids (amino acids peptides and proteins)GLUT1Blood sugar regulationInternational Journal of Molecular Sciences
researchProduct

Beta-glucans and cancer: The influence of inflammation and gut peptide

2017

Dietary β-glucans are soluble fibers with potentially health-promoting effects. Gut peptides are important signals in the regulation of energy and glucose homeostasis. This article reviews the effects of different enriched β-glucan food consumption on immune responses, inflammation, gut hormone and cancer. Gut hormones are influenced by enriched β-glucan food consumption and levels of such peptide as YY, ghrelin, glucagon-like peptide 1 and 2 in humans influence serum glucose concentration as well as innate and adaptive immunity. Cancer cell development is also regulated by obesity and glucose dishomeostasy that are influenced by β-glucan food consumption that in turn regulated gut hormones.

0301 basic medicinemedicine.medical_specialtybeta-GlucansInflammationbeta-Glucan03 medical and health sciences0302 clinical medicineImmune systemGlucagon-Like Peptide 1Functional FoodNeoplasmsInternal medicineβ-GlucanDrug DiscoveryGlucagon-Like Peptide 2medicineAnimalsHumansInsulinGlucose homeostasisPeptide YYCancerInflammationPharmacologyPYYAnimalChemistryDrug Discovery3003 Pharmaceutical Sciencedigestive oral and skin physiologyOrganic ChemistryGeneral MedicineGlucagon-like peptide-2Glucagon-like peptide-1GhrelinGlucose030104 developmental biologyEndocrinology030220 oncology & carcinogenesisPeptide YYNeoplasmGhrelinmedicine.symptomGLP-1GLP-2HumanHormoneEuropean Journal of Medicinal Chemistry
researchProduct

Association between ribs shape and pulmonary function in patients with Osteogenesis Imperfecta

2019

Graphical abstract

0301 basic medicinemusculoskeletal diseasesVital capacityPulmonary functionMedicinaKyphosisScoliosisPulmonary function testing03 medical and health sciencesFEV1/FVC ratio0302 clinical medicinemedicineRespiratory functionLung volumeslcsh:Science (General)ComputingMethodologies_COMPUTERGRAPHICSRib cagelcsh:R5-920Geometric morphometricsMultidisciplinarybusiness.industryAnatomymedicine.diseasemusculoskeletal system030104 developmental biologyScoliosis030220 oncology & carcinogenesisRib cageOriginal ArticleOsteogenesis imperfectaThoracic spinebusinesslcsh:Medicine (General)lcsh:Q1-390Journal of Advanced Research 21: 177-185 (2020)
researchProduct

Fluorescent pseudomonads harboring type III secretion genes are enriched in the mycorrhizosphere of Medicago truncatula

2011

Type III secretion systems (T3SSs) of Gram-negative bacteria mediate direct interactions with eukaryotic cells. Pseudomonas spp. harboring T3SS genes (T3SS+) were previously shown to be more abundant in the rhizosphere than in bulk soil. To discriminate the contribution of roots and associated arbuscular mycorrhizal fungi (AMF) on the enrichment of T3SS+ fluorescent pseudomonads in the rhizosphere of Medicago truncatula, their frequency was assessed among pseudomonads isolated from mycorrhizal and nonmycorrhizal roots and from bulk soil. T3SS genes were identified by PCR targeting a conserved hrcRST DNA fragment. Polymorphism of hrcRST in T3SS+ isolates was assessed by PCR-restriction fragm…

0303 health sciencesRhizosphereEcology030306 microbiologyPseudomonasBulk soilMycorrhizospherePseudomonas fluorescensbiochemical phenomena metabolism and nutritionBiologybacterial infections and mycosesbiology.organism_classificationApplied Microbiology and BiotechnologyMicrobiologyMedicago truncatulaMicrobiology03 medical and health sciencesBotanybacteriaMycorrhizaSoil microbiology030304 developmental biologyFEMS Microbiology Ecology
researchProduct

Digestion of bamboo compared to grass and lucerne in a small hindgut fermenting herbivore, the guinea pig (Cavia porcellus)

2022

Bamboo is an enigmatic forage, representing a niche food for pandas and bamboo lemurs. Bamboo might not represent a suitable forage for herbivores relying on fermentative digestion, potentially due to its low fermentability. To test this hypothesis, guinea pigs (n = 36) were used as model species and fed ad libitum with one of three forages (bamboo, lucerne, or timothy grass) in a fresh or dried state, with six individuals per group, for 3 weeks. The nutrient composition and in vitro fermentation profile of bamboo displayed low fermentation potential, i.e. high lignin and silica levels together with a gas production (Hohenheim gas test) at 12 h of only 36% of that of lucerne and grass. Alth…

10253 Department of Small AnimalsAnimal NutritionPhysiologydigestionLigninNutrientfermentation2. Zero hunger0303 health sciencesTimothy-grassbamboo630 AgricultureEcologybiologyfood and beverages04 agricultural and veterinary sciencesSilicon DioxideDiervoedingDigestionMedicago sativaBambooEvolutionGuinea PigsCaviaForagePoaceae03 medical and health sciencesAnimal science1311 GeneticsBehavior and Systematics1312 Molecular BiologyGeneticsAnimalsDry matterHerbivoryMolecular BiologyEcology Evolution Behavior and Systematics030304 developmental biology0402 animal and dairy science1314 Physiologybiology.organism_classificationAnimal Feed040201 dairy & animal science1105 Ecology Evolution Behavior and SystematicsWIAS570 Life sciences; biologyAnimal Science and ZoologyFermentation1103 Animal Science and Zoologyguinea pig
researchProduct